Daxor Corporation
Daxor Corporation (DXR) Financial Performance & Income Statement Overview
Analyze Daxor Corporation (DXR) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Daxor Corporation (DXR) Income Statement & Financial Overview
Explore comprehensive income reports for Daxor Corporation DXR, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $695307.00 | $71756.00 | $36.35M | $41224.00 |
| Cost of Revenue | $74644.00 | $0.00 | -$4636.00 | $0.00 |
| Gross Profit | $620663.00 | $71756.00 | $36.36M | $41224.00 |
| Gross Profit Ratio | $0.89 | $1.00 | $1.000 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | -$1.58M | $369306.00 | $251508.00 | $251508.00 |
| Operating Expenses | $585231.00 | $369306.00 | $1.62M | $1.62M |
| Total Costs & Expenses | $1.51M | $369306.00 | $33.29M | $1.62M |
| Interest Income | $0.00 | $0.00 | $0.00 | $2318.00 |
| Interest Expense | $0.00 | $0.00 | $4636.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $300836.00 | $210793.00 | $210793.00 |
| EBITDA | $2.21M | -$3.17M | $3.06M | $0.00 |
| EBITDA Ratio | $3.17 | -$44.15 | $0.08 | $45.35 |
| Operating Income | $2.21M | -$297550.00 | $3.06M | -$210793.00 |
| Operating Income Ratio | $3.17 | -$4.15 | $0.08 | -$5.11 |
| Other Income/Expenses (Net) | -$38170.00 | -$2.96M | $252969.00 | $1.87M |
| Income Before Tax | $2.17M | -$3.26M | $3.32M | $1.66M |
| Income Before Tax Ratio | $3.12 | -$45.45 | $0.09 | $40.24 |
| Income Tax Expense | $0.00 | -$1.63M | $1.00 | $1.87M |
| Net Income | $2.17M | -$1.63M | $3.32M | $1.66M |
| Net Income Ratio | $3.12 | -$22.73 | $0.09 | $40.24 |
| EPS | $0.44 | -$0.34 | $0.69 | $0.35 |
| Diluted EPS | $0.44 | -$0.34 | $0.69 | $0.35 |
| Weighted Avg Shares Outstanding | $4.93M | $4.83M | $4.81M | $4.81M |
| Weighted Avg Shares Outstanding (Diluted) | $4.93M | $4.83M | $4.81M | $4.81M |
Over the last four quarters, Daxor Corporation achieved steady financial progress, growing revenue from $41224.00 in Q3 2023 to $695307.00 in Q4 2024. Gross profit stayed firm with margins at 89% in Q4 2024 versus 100% in Q3 2023. Operating income totaled $2.21M in Q4 2024, maintaining a 317% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $2.21M. Net income rose to $2.17M, with EPS at $0.44. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan